Advances in Hematological Malignancies
Recent centuries have witnessed remarkable advancements in the area of hematological malignancies. Novel therapies such as targeted therapy, immunotherapies, and gene editing are revolutionizing the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering potential for more successful